Leronlimab
Product Specifications
CAS Number
674782-26-4
Target
HIV Protease, CCR
Related Pathways
Proteases/Proteasome, Microbiology/Virology, GPCR/G Protein, Immunology/Inflammation
Purity
0.996
Bioactivity
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody with both anti-HIV and anti-tumor activity, inhibiting CCR-mediated HIV-1 virus and cancer cell metastasis in mouse tumor models. Leronlimab can be used to study HIV, non-alcoholic steatohepatitis (NASH), and breast cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1472051-01 0.02 mg (E-Coli)
Recombinant Synechococcus sp. Tryptophan--tRNA ligase (trpS)
Sign In for Pricing
View Details 
MBS1472051-02 0.02 mg (Yeast)
Recombinant Synechococcus sp. Tryptophan--tRNA ligase (trpS)
Sign In for Pricing
View Details 
MBS1472051-03 0.1 mg (E-Coli)
Recombinant Synechococcus sp. Tryptophan--tRNA ligase (trpS)
Sign In for Pricing
View Details 
MBS1472051-04 0.1 mg (Yeast)
Recombinant Synechococcus sp. Tryptophan--tRNA ligase (trpS)
Sign In for Pricing
View Details MBS1472051-05 0.02 mg (Baculovirus)
Recombinant Synechococcus sp. Tryptophan--tRNA ligase (trpS)
Sign In for Pricing
View Details MBS1472051-06 0.02 mg (Mammalian-Cell)
Recombinant Synechococcus sp. Tryptophan--tRNA ligase (trpS)
Sign In for Pricing
View Details